Bajaj HealthCare Limited
NSE: BAJAJHCARE BSE: BAJAJHCARE
NSE
418.65
5.90 (1.43%)
Prev Close
412.75
Open Price
413.2
Volume
176,658
Today Low / High
409 / 425.35
52 WK Low / High
393.45 / 745
Range
398 - 440
BSE
418.50
4.85 (1.17%)
Prev Close
413.65
Open Price
413.65
Volume
22,695
Today Low / High
409 / 424.85
52 WK Low / High
394.1 / 744.9
Range
398 - 439
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 418.65 (target range: 398 - 440), reflecting a change of 5.9 (1.42944%). On the BSE, it is listed at 418.5 (target range: 398 - 439), showing a change of 4.85 (1.17249%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
19 Dec
413.20
1.32%
18 Dec
402.50
2.55%
17 Dec
415.00
-3.35%
16 Dec
411.10
-0.04%
15 Dec
411.25
-0.27%
12 Dec
412.55
0.11%
11 Dec
415.10
-0.66%
10 Dec
415.60
0.55%
09 Dec
401.10
3.62%
08 Dec
422.50
-3.79%
05 Dec
423.10
-0.82%
04 Dec
420.00
1.00%
03 Dec
428.00
-1.43%
02 Dec
430.00
-0.63%
01 Dec
432.50
-0.44%
28 Nov
429.95
0.58%
27 Nov
431.60
-1.15%
26 Nov
428.00
-0.27%
25 Nov
426.55
0.63%
24 Nov
425.90
0.26%
Bajaj HealthCare Limited Graph
Bajaj HealthCare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Bajaj HealthCare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 418.65, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 418.50 | 422.69 | 380.42 - 464.95 |
| 426.87 | 341.50 - 512.24 | ||
| 431.06 | 301.74 - 560.37 | ||
| Bearish Scenario | 418.50 | 414.32 | 372.88 - 455.75 |
| 410.13 | 328.10 - 492.16 | ||
| 405.95 | 284.16 - 527.73 |
Overview of Bajaj HealthCare Limited
ISIN
INE411U01027
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
246,101
Market Cap
13,222,328,450
Last Dividend
1
Official Website
IPO Date
2021-11-25
DCF Diff
814.01
DCF
-395
Financial Ratios Every Investor Needs
Stock Dividend of BAJAJHCARE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-19 | September 19, 25 | 1 | 1 | 2025-09-19 | 2025-10-26 | |
| 2024-09-23 | September 23, 24 | 1 | 1 | 2024-09-23 | 2024-10-30 | |
| 2023-09-22 | September 22, 23 | 1 | 1 | 2023-09-23 | 2023-10-30 | |
| 2022-09-22 | September 22, 22 | 1.5 | 1.5 | 2022-09-23 | 2022-10-30 | |
| 2021-09-28 | September 28, 21 | 0.5 | 0.5 | 2021-09-29 | 2021-10-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 542.60 Cr | 371.42 Cr | 171.18 Cr | 0.3155 | 0.00 Cr | 57.06 Cr | 54.51 Cr | 39.50 Cr | 13.29 | 101.83 Cr | 0.0728 |
| 2024-03-31 | 473.42 Cr | 259.13 Cr | 214.29 Cr | 0.4526 | 1.63 Cr | 5.74 Cr | 48.71 Cr | -83.79 Cr | -30.36 | 40.62 Cr | -0.1770 |
| 2023-03-31 | 645.80 Cr | 490.66 Cr | 133.15 Cr | 0.2062 | 3.80 Cr | 47.84 Cr | 96.16 Cr | 43.02 Cr | 15.59 | 121.94 Cr | 0.0666 |
| 2022-03-31 | 679.22 Cr | 495.39 Cr | 183.84 Cr | 0.2707 | 2.61 Cr | 6.96 Cr | 105.95 Cr | 71.39 Cr | 25.87 | 119.95 Cr | 0.1051 |
| 2021-03-31 | 655.78 Cr | 462.93 Cr | 192.86 Cr | 0.2941 | 4.53 Cr | 5.57 Cr | 124.81 Cr | 83.11 Cr | 30.11 | 143.28 Cr | 0.1267 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.60 Cr | 833.05 Cr | 366.88 Cr | 466.1642 Cr | 223.25 Cr | 218.80 Cr | 161.89 Cr | 240.49 Cr | 0.00 Cr | 0.00 Cr | 2.86 Cr | 272.2662 Cr |
| 2024-03-31 | 2.17 Cr | 765.13 Cr | 486.77 Cr | 278.3609 Cr | 332.82 Cr | 330.65 Cr | 144.04 Cr | 257.56 Cr | 0.31 Cr | 0.00 Cr | 1.95 Cr | 441.4792 Cr |
| 2023-03-31 | 17.72 Cr | 901.46 Cr | 533.77 Cr | 367.6894 Cr | 415.24 Cr | 397.52 Cr | 208.79 Cr | 387.42 Cr | 28.29 Cr | 2.79 Cr | 9.84 Cr | 436.0596 Cr |
| 2022-03-31 | 1.98 Cr | 721.10 Cr | 392.62 Cr | 328.4855 Cr | 256.74 Cr | 254.76 Cr | 159.26 Cr | 321.72 Cr | 25.56 Cr | 68.98 Cr | 0.00 Cr | 322.0730 Cr |
| 2021-03-31 | 14.24 Cr | 525.63 Cr | 267.22 Cr | 258.4105 Cr | 180.89 Cr | 166.64 Cr | 97.11 Cr | 265.18 Cr | 10.95 Cr | 0.00 Cr | -0.66 Cr | 182.5733 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -5.7780 Cr | -15.3210 Cr | 21.5281 Cr | -17.3165 Cr | 2.2761 Cr | 4.4508 Cr | -11.5385 Cr | 42.9288 Cr | -125.2805 Cr | -2.7598 Cr | -17.8495 Cr |
| 2024-03-31 | 92.2944 Cr | -11.2446 Cr | -96.5955 Cr | 62.0081 Cr | -15.5457 Cr | 2.1747 Cr | -30.2863 Cr | -14.3266 Cr | -51.7296 Cr | -2.7598 Cr | 20.4204 Cr |
| 2023-03-31 | -22.3237 Cr | -93.4267 Cr | 131.4958 Cr | -146.1657 Cr | 15.7454 Cr | 17.7204 Cr | -123.8420 Cr | 58.2163 Cr | 158.5079 Cr | -4.1398 Cr | -49.5249 Cr |
| 2022-03-31 | 0.6860 Cr | -74.7984 Cr | 61.8463 Cr | -78.6189 Cr | -12.2662 Cr | 1.9749 Cr | -79.3049 Cr | 89.6846 Cr | 75.8501 Cr | -1.3800 Cr | -62.1515 Cr |
| 2021-03-31 | 43.5583 Cr | -108.9330 Cr | 75.4573 Cr | -70.2304 Cr | 10.0826 Cr | 14.2411 Cr | -113.7887 Cr | 118.8197 Cr | 86.1681 Cr | -2.4149 Cr | -57.8352 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 147.91 Cr | 97.19 Cr | 50.72 Cr | 0.3429 | 19.86 Cr | 11.11 Cr | 3.52 | 28.59 Cr | 0.0751 |
| 2025-06-30 | 148.84 Cr | 80.59 Cr | 68.25 Cr | 0.4585 | 18.87 Cr | 11.83 Cr | 3.74 | 25.39 Cr | 0.0795 |
| 2025-03-31 | 154.47 Cr | 117.21 Cr | 37.27 Cr | 0.2413 | 4.23 Cr | 11.18 Cr | 3.48 | 25.33 Cr | 0.0724 |
| 2024-12-31 | 122.79 Cr | 60.91 Cr | 61.88 Cr | 0.5039 | 14.79 Cr | 11.72 Cr | 3.65 | 24.01 Cr | 0.0955 |
| 2024-09-30 | 133.09 Cr | 65.98 Cr | 67.11 Cr | 0.5042 | 17.72 Cr | 9.46 Cr | 3.36 | 27.13 Cr | 0.0711 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 14.01 Cr | 0.00 Cr | 14.01 Cr | 231.94 Cr | 156.31 Cr | 472.88 Cr | 252.55 Cr | 838.87 Cr | 352.47 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 4.45 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -466.16 Cr |
| 2025-03-31 | 4.45 Cr | 0.00 Cr | 4.45 Cr | 251.67 Cr | 161.89 Cr | 485.40 Cr | 240.49 Cr | 833.05 Cr | 366.88 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 22.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -445.83 Cr |
| 2024-09-30 | 21.47 Cr | 36.53 Cr | 58.00 Cr | 216.86 Cr | 142.43 Cr | 531.07 Cr | 248.29 Cr | 803.95 Cr | 358.12 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 11.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 11.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 11.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 9.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 7.13 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,744.90 | ₹4,186,599,589,153.00 | ₹2,768,881.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,478.50 | ₹1,719,838,195,530.00 | ₹785,191.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,800.30 | ₹1,286,194,205,632.00 | ₹150,391.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,278.20 | ₹1,064,117,509,455.00 | ₹1,209,451.00 |
| Lupin Limited | LUPIN | ₹2,125.80 | ₹971,062,901,795.00 | ₹595,983.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹919.60 | ₹925,332,777,204.00 | ₹799,832.00 |
| Mankind Pharma Limited | MANKIND | ₹2,172.10 | ₹896,653,896,891.00 | ₹491,290.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,225.10 | ₹711,540,068,337.00 | ₹1,396,498.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,555.50 | ₹664,243,357,500.00 | ₹51,668.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,045.20 | ₹564,258,099,506.00 | ₹2,843,487.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,992.10 | ₹562,172,231,609.00 | ₹527,752.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,424.80 | ₹361,477,769,806.00 | ₹169,772.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,632.60 | ₹328,905,523,742.00 | ₹110,006.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,805.70 | ₹282,864,631,249.00 | ₹90,439.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,385.00 | ₹262,547,317,250.00 | ₹43,519.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,411.10 | ₹229,292,699,676.00 | ₹3,916,644.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,091.50 | ₹227,287,500,000.00 | ₹5,946.00 |
| Eris Lifesciences Limited | ERIS | ₹1,571.60 | ₹214,078,465,896.00 | ₹36,657.00 |
| Cohance Lifesciences Limited | COHANCE | ₹538.45 | ₹205,993,276,533.00 | ₹739,838.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹16,044.00 | ₹205,842,739,116.00 | ₹80,404.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,087.10 | ₹172,303,648,689.00 | ₹385,335.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹859.90 | ₹169,024,630,328.00 | ₹65,161.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹916.75 | ₹164,198,973,323.00 | ₹828,152.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,926.90 | ₹146,466,937,022.00 | ₹23,449.00 |
| Granules India Limited | GRANULES | ₹583.40 | ₹141,572,928,914.00 | ₹2,092,706.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹900.65 | ₹110,492,956,076.00 | ₹28,666.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,662.00 | ₹93,985,700,884.00 | ₹8,085.00 |
| Strides Pharma Science Limited | STAR | ₹930.80 | ₹85,794,362,191.00 | ₹1,135,299.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹747.10 | ₹67,722,593,347.00 | ₹138,130.00 |
| FDC Limited | FDC | ₹411.00 | ₹66,914,944,524.00 | ₹44,533.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹427.20 | ₹65,405,199,178.00 | ₹79,062.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹324.75 | ₹63,515,194,746.00 | ₹217,012.00 |
| Sequent Scientific Limited | SEQUENT | ₹210.32 | ₹52,542,945,612.00 | ₹611,339.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹143.82 | ₹46,672,694,786.00 | ₹5,389,949.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹404.95 | ₹44,125,484,062.00 | ₹842,528.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹787.05 | ₹39,918,471,590.00 | ₹47,648.00 |
| Innova Captab Limited | INNOVACAP | ₹689.25 | ₹39,442,282,313.00 | ₹23,459.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,343.40 | ₹38,757,527,751.00 | ₹4,275.00 |
| Suven Life Sciences Limited | SUVEN | ₹171.00 | ₹37,689,428,565.00 | ₹168,450.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹349.00 | ₹34,998,594,594.00 | ₹19,683.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹381.55 | ₹34,824,068,500.00 | ₹204,900.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹449.80 | ₹31,668,506,350.00 | ₹12,331.00 |
| Hikal Limited | HIKAL | ₹237.11 | ₹29,235,840,833.00 | ₹187,426.00 |
Key Executives
Executive Vice President Sales & Marketing
Prasad
Gender: male
Year Born:
Chief Technical Officer
Amit Rajan M.Tech
Gender: male
Year Born:
Vice Chairman & Joint MD
Anil Champalal Jain
Gender: male
Year Born: 1975
Senior Vice President of Operations and Unit II Head- Salvi
Nandkumar R. Soni
Gender: male
Year Born:
Whole Time Director
Pakshal Anil Jain
Gender: male
Year Born: 1998
Whole Time Director
Namrata Sajankumar Bajaj
Gender: female
Year Born: 1986
Chief Financial Officer
Rohan Parekh
Gender: male
Year Born:
Founder, Chairman & MD
Sajankumar Rameshwarlal Bajaj
Gender: male
Year Born: 1960
Chief Operating Officer
Shreekumar Shankarnarayan Nair
Gender: male
Year Born: 1960
Company Secretary & Compliance Officer
Monica Tanwar
Gender: female
Year Born:
FAQs about Bajaj HealthCare Limited
Who is the CEO of the company?
The CEO is Sajankumar Rameshwarlal Bajaj.
What is the current market price of the stock?
The current price is ₹418.65.
What is the 52-week price range?
The range is ₹393.45-745.
What is the market capitalization of the company?
The market capitalization is ₹1,322.23 crores.
What is the dividend yield?
The dividend yield is 0.24%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 28.84.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Bajaj HealthCare Limited (ISIN: INE411U01027) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹1,322.23 crores and an average daily volume of 246,101 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹1.